Private Equity and Dermatology-First, Do No Harm

被引：20

作者：

Sharfstein, Joshua M. ^{[1
]}

Slocum, Jamar ^{[2
]}

机构：

[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Gen Prevent Med Program, Baltimore, MD USA

来源：

JAMA DERMATOLOGY | 2019年 / 155卷 / 09期

关键词：

D O I：

10.1001/jamadermatol.2019.1322

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1007 / 1008

页数：2

共 12 条

[1]

Ahmed Nabila, 2017, BLOOMBERG

[2] Further thoughts on dermatology and equity-owned dermatology practices [J].

Bennett, Richard G. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) :E11-E12

[3]

Brown Gibbons Lang & Co, SKIN GAM GROW PRIV C

[4]

Bundy WC, DERMATOLOGY PRACTICE

[5]

Covert Bryce., 2018, The Atlantic

[6]

Hafner K, 2017, NY TIMES

[7]

Hsu Albert, 2018, Mo Med, V115, P333

[8] Future considerations for clinical dermatology in the setting of 21st century American policy reform: Corporatization and the rise of private equity in dermatology [J].

Konda, Sailesh ;

Francis, Joseph ;

Motaparthi, Kiran ;

Grant-Kels, Jane M. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) :287-+

[9] A Day at the Office: Private Practice and Private Equity [J].

Lundy, Douglas W. .

CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2019, 477 (05) :955-957

[10] Dermatology Practice Consolidation Fueled by Private Equity Investment Potential Consequences for the Specialty and Patients [J].

Resneck, Jack S., Jr. .

JAMA DERMATOLOGY, 2018, 154 (01) :13-14

← 1 2 →